Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986-2000

被引:18
作者
Trampuz, A
Widmer, AF
Fluckiger, U
Haenggi, M
Frei, R
Zimmerli, W
机构
[1] Univ Basel Hosp, Dept Clin Epidemiol, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Bacteriol Lab, CH-4031 Basel, Switzerland
[3] Univ Hosp, Dept Internal Med, Div Infect Dis, Basel, Switzerland
[4] Univ Med Clin, Liestal, Switzerland
关键词
D O I
10.4065/79.5.604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate changes in epidemiological characteristics and outcome of patients with pneumococcal bacteremia during a 15-year period in a Swiss university hospital. Patients and Methods: We reviewed the medical records of all hospitalized adults at the University Hospital Basel, Basel, Switzerland, whose blood culture yielded Streptococcus pneunioniae from January 1, 1986, through December 31, 2000. Results: We analyzed 405 episodes of pneumococcal bacteremia in 394 patients. The mean annual incidence of 1.78 episodes per 1000 hospital admissions was inversely related to the mean atmospheric temperature of the area. During the study period, penicillin nonsusceptibility increased from 0% to 17%. The overall case-fatality rate was 25%, which decreased from 33% to 17% between the first and the second half of the study period (P<.001). The proportion of women with pneumococcal bacteremia increased from 37% to 52%. Independent risk factors for fatal outcome were coronary artery disease (P<.001; relative risk [RR], 4.3; 95 % confidence interval [CI], 3.4-5.1), neutropenia (P=.001; RR, 3.2; 95 % CI, 1.9-4.8), and age 65 years or older (P=.001; RR, 2.9; 95 % CI, 1.8-4.2), whereas prior respiratory tract infection (P=.03; RR, 0.3; 95 % CI, 0.1-0.5) and the occurrence of pneumococcal bacteremia in the second half of the study period (P=.01; RR, 0.4; 95% CI, 0.2-0.6) were independent predictors of survival. The case-fatality rate in human immunodeficiency virus (HIV)-infected patients was significantly lower than in patients not infected with HIV or in those with unknown HIV status (9% vs 27%; P=.006), which correlated with the younger mean +/- SD age of HIV-infected patients (33.2+/-6.6 years) compared with patients not infected with HIV (63.1+/-18.1 years) (P<001). Conclusions: The case-fatality rate of patients with pneumococcal bacteremia decreased significantly between the first and second half of the study period, despite the increased prevalence of penicillin-nonsusceptible isolates. Independent risk factors for fatal outcome were coronary artery disease, neutropenia, and age 65 years or older, whereas prior respiratory tract infection and the occurrence of pneumococcal bacteremia in the second half of the study period were independent predictors of survival. HIV infection was a predisposing factor for pneumococcal bacteremia but was not a risk factor for fatal outcome.
引用
收藏
页码:604 / 612
页数:9
相关论文
共 45 条
[1]   PNEUMOCOCCAL BACTEREMIA IN ADULTS - A 14-YEAR EXPERIENCE IN AN INNER-CITY UNIVERSITY HOSPITAL [J].
AFESSA, B ;
GREAVES, WL ;
FREDERICK, WR .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (02) :345-351
[2]   Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore [J].
Albanese, BA ;
Roche, JC ;
Pass, M ;
Whitney, CG ;
McEllistrem, MC ;
Harrison, LH .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :15-21
[3]   PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA [J].
AUSTRIAN, R ;
GOLD, J .
ANNALS OF INTERNAL MEDICINE, 1964, 60 (05) :759-+
[4]   The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the centers for disease control and prevention's pneumococcal sentinel surveillance system [J].
Butler, JC ;
Hofmann, J ;
Cetron, MS ;
Elliott, JA ;
Facklam, RR ;
Breiman, RF ;
Camp, C ;
Charache, P ;
Dern, R ;
Jackson, M ;
Hadley, WK ;
HoppeBauer, J ;
Jacobs, MR ;
Schreiber, J ;
Boxerbaum, B ;
Menuey, BC ;
Tyler, PG ;
Monahan, J ;
Moore, H ;
Siegel, JD ;
Sherer, D ;
Rogers, P ;
Welch, D ;
Fine, D ;
Radike, J ;
Fiore, A ;
Alexander, M ;
Deaver, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :986-993
[5]   Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J].
Byl, B ;
Clevenbergh, P ;
Jacobs, F ;
Struelens, MJ ;
Zech, F ;
Kentos, A ;
Thys, JP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :60-66
[6]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1
[7]   Recurrent pneumococcal bacteremia: 34 episodes in 15 patients [J].
Coccia, MR ;
Facklam, RR ;
Saravolatz, LD ;
Manzor, O .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :982-985
[8]   Seasonal patterns of invasive pneumococcal disease [J].
Dowell, SF ;
Whitney, CG ;
Wright, C ;
Rose, CE ;
Schuchat, A .
EMERGING INFECTIOUS DISEASES, 2003, 9 (05) :573-579
[9]  
Ekdahl K, 1998, SCAND J INFECT DIS, V30, P257, DOI 10.1080/00365549850160891
[10]   Prognostic factors for pneumococcal bacteremia in a university hospital [J].
Fariñas-Alvarez, C ;
Fariñas, MC ;
García-Palomo, JD ;
González-Ruiz, M ;
Fernández-Mazarrasa, C ;
Parra, JS ;
González-Macías, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (10) :733-741